Accelerate digital health research using platform and expertise developed in close collaboration with the National Institutes of Health
Vibrent seamlessly weaves participant-focused technologies into the entire life cycle of clinical research. Accelerate recruitment, retention and engagement of diverse populations and harmonize novel data collected - genotype, phenotype, medical and environmental context.
View use cases
Vibrent provides a robust, privacy preserving Digital Health Research Solutions Platform for clinical research in collaboration with the National Institutes of Health (NIH).
A data-first approach across the entire research lifecycle of outreach, awareness, recruitment, data collection, engagement and retention.
A single platform that replaces your multiple vendors
Approved by many IRBs
Fast deployment
000
M+000000
+
00
%+00000
+Whether you are competing for grants or pursuing new revenue; the keys to your success are generating novel datasets and recruiting, engaging and retaining diverse populations.
Make your budget go further. Workflow automation and digital marketing reduces labor costs. Robust virtual data collection methods helps you collect higher quality data sets at a lower cost. Cloud-based research tools drive efficiencies throughout the entire life cycle of your clinical research.
REQUEST A PILOT
One platform, one partner for your digital health research needs. Co-developed with the NIH. Proven at with over 400,000 participants and over 1,000 study staff.
View ProductsOur team of subject matter experts will help you through every stage of the process. Need help with IRB submission, electronic consent design, EHR setup, remote sampling kits, selecting the right wearable and medical device technologies or recruitment/
retention/engagement strategies? We’re here for you.
How Dana-Farber Cancer Institute Created a Digital Cancer Registry to Improve Cancer Research and Maximize Patient Engagement
How Dana-Farber Cancer Institute Created a Digital Cancer Registry to Improve Cancer Research and Maximize Patient Engagement Study Overview and…
eConsent Frequently Asked Questions
There are many questions that researchers have In seeking to understand and implement eConsent. We compiled a list of some…
How Mount Sinai Delivers eConsent and Phenotypic and EHR Data Collection for Its Million Person Genomics Research Program
How Mount Sinai Delivers eConsent and Phenotypic and EHR Data Collection for Its Million Person Genomics Research Program Background Genomic…
5 common social media mistakes in health research participant engagement
Social media continues to grow as a powerful tool for health researchers to recruit the right populations for their trials…
All of Us Research Program Releases Genomic Data to Researchers, Combined with Participant-Generated Data Collected on Vibrent Health’s Digital Health Research Platform
FAIRFAX, Va., March 18, 2022 – The National Institutes of Health’s All of Us Research Program has made its initial genomic dataset available,…
Vibrent Health to Launch Integrated Platform for Ancillary Studies in Large-Cohort Digital Health Research
FAIRFAX, Va.--March 1, 2022--Vibrent Health, a health technology startup powering the future of precision health research, announced the development of…
Why Diversity In Health Research Is Good Science And Good Business
Recruiting and retaining participants for clinical research — let alone those that represent diverse populations — has historically been a…
Designing Surveys for Data Collection: An Interview with a Survey Methodologist
In health research, clinical and lab data only go so far. Researchers often want to perform data collection about people’s…
Vibrent Health powers NIH precision nutrition research project to accelerate discoveries in food and dietary patterns
FAIRFAX, Va., Jan. 20, 2022 – Vibrent Health, a health technology startup powering the future of precision health research, today…
Ethical AI can promote diversity in clinical research
In a clinical research ecosystem that’s not known for its diversity, AI brings something meaningful to the table — but…